Sidley Austin and Moelis & Company have advised ARCHIMED. Goodwin Procter and Centerview Partners have advised Esperion Therapeutics. Akin Gump has advised Pharmakon Advisors. ARCHIMED, a...
ARCHIMED Acquires Esperion Therapeutics in $1.1 Billion Transaction
Centerbridge Partners to Acquire MeridianLink in $2 Billion All-Cash Transaction
Kirkland & Ellis has advised Centerbridge Partners, and Goodwin Procter has advised MeridianLink. Skadden has advised Thoma Bravo, MeridianLink, Inc.’s largest shareholder. Paul Hastings LLP represented...
AVROBIO’s Merger with Tectonic Therapeutic
Leerink Partners is serving as exclusive financial advisor to Tectonic and Cooley LLP is serving as legal counsel to Tectonic. Leerink Partners and TD Cowen are...
Merck’s $680 Million Acquisition of Harpoon Therapeutics
Evercore Group L.L.C. acted as financial advisor to Merck in this transaction and Covington & Burling LLP acted as its legal advisor. Centerview Partners LLC acted...
Braidwell’s $200 Million Term Loan and Warrant Investment in Nevro Corp.
Goodwin advised Braidwell, LP on the matter. Braidwell, LP announced the consummation of an additional investment in Nevro Corp. (NYSE: NVRO), consisting of a six-year, $200,000,000 senior...
York Capital Management’s Partnership with Comprehensive Rehab Consultants
Goodwin Procter advised York Capital Management in its strategic growth investment in Comprehensive Rehab Consultants. William Blair acted as the sell-side investment banking advisor to CRC....
Kyowa Kirin’s $387 Million Acquisition of Orchard Therapeutics
Kyowa Kirin was represented by Goldman Sachs Japan Co., Ltd. as financial advisor and Morrison & Foerster LLP. as legal advisor. Orchard Therapeutics was represented by...
Bregal Sagemount’s Strategic Growth Investment in Bradford Airport Logistics
Goodwin Procter and Allen & Overy advised Sagemount, while Sidley advised Bradford Airport Logistics on the deal. Bradford Airport Logistics announced that it received a significant growth...
Revolution Medicines’ Acquisition of EQRx
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
Bobbie’s Acquisition of Nature’s One
Goodwin advises Bobbie on the acquisition. Pillsbury advises PowerPlant Partners on its investment. Bobbie announced the acquisition of Nature’s One. The industry-disrupting acquisition allows Bobbie, the...
Eli Lilly’s $1.925 Billion Acquisition of Versanis Bio
Kirkland & Ellis acted as legal counsel to Eli Lilly, while for Versanis, Goodwin Procter acted as legal counsel and Cooley advised as to patent matters....
Charm Industrial’s $100 Million Series B Financing Round
Goodwin advised Charm Industrial on the fundraising. Charm Industrial announced its $100 million Series B Preferred Stock financing. The round was led by General Catalyst with...